PDE4A and depressive disorder: This study investigated the effects of roflumilast (PDE4 inhibitor) on the activity of the PRKACA-CREB-BDNF signaling pathway, pro-inflammatory cytokine production and change in hippocampal histology in male Wistar rats exposed to CRS model of depression.